» Articles » PMID: 35741402

MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2022 Jun 24
PMID 35741402
Authors
Affiliations
Soon will be listed here.
Abstract

The oncogenic transcription factor c-MYC (MYC) is highly conserved across species and is frequently overexpressed or dysregulated in human cancers. MYC regulates a wide range of critical cellular and oncogenic activities including proliferation, metabolism, metastasis, apoptosis, and differentiation by transcriptionally activating or repressing the expression of a large number of genes. This activity of MYC is not carried out in isolation, instead relying on its association with a myriad of protein cofactors. We determined that MDM Two Binding Protein (MTBP) indirectly binds MYC and is a novel MYC transcriptional cofactor. MTBP promotes MYC-mediated transcriptional activity, proliferation, and cellular transformation by binding in a protein complex with MYC at MYC-bound promoters. This discovery provided critical context for data linking MTBP to aging as well as a rapidly expanding body of evidence demonstrating MTBP is overexpressed in many human malignancies, is often linked to poor patient outcomes, and is necessary for cancer cell survival. As such, MTBP represents a novel and potentially broad reaching oncologic drug target, particularly when MYC is dysregulated. Here we have reviewed the discovery of MTBP and the initial controversy with its function as well as its associations with proliferation, MYC, DNA replication, aging, and human cancer.

Citing Articles

Construction and validation of a senescence-related gene signature for early prediction and treatment of osteoarthritis based on bioinformatics analysis.

Wang Y, Li Z, Xu X, Li X, Huang R, Wu G Sci Rep. 2024; 14(1):31862.

PMID: 39738612 PMC: 11686076. DOI: 10.1038/s41598-024-83268-9.


Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers.

Shen C, Geng R, Zhu S, Huang M, Liang J, Li B Am J Clin Exp Immunol. 2024; 13(4):187-194.

PMID: 39310123 PMC: 11411158. DOI: 10.62347/XMZW6604.


Characterization of an Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model.

Ranjan A, Thoenen E, Kaida A, Wood S, Van Dyke T, Iwakuma T Cancers (Basel). 2023; 15(18).

PMID: 37760565 PMC: 10526184. DOI: 10.3390/cancers15184596.


Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Sahni S, Nahm C, Ahadi M, Sioson L, Byeon S, Chou A Cancer Med. 2023; 12(17):18050-18061.

PMID: 37533202 PMC: 10523964. DOI: 10.1002/cam4.6411.


PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma.

Peng S, Wang Z, Tang P, Wang S, Huang Y, Xie Q Sci Adv. 2023; 9(31):eadf3566.

PMID: 37531433 PMC: 10396305. DOI: 10.1126/sciadv.adf3566.


References
1.
Odvody J, Vincent T, Arrate M, Grieb B, Wang S, Garriga J . A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene. 2010; 29(22):3287-96. PMC: 2880662. DOI: 10.1038/onc.2010.82. View

2.
Kohler K, Sanchez-Pulido L, Hofer V, Marko A, Ponting C, Snijders A . The Cdk8/19-cyclin C transcription regulator functions in genome replication through metazoan Sld7. PLoS Biol. 2019; 17(1):e2006767. PMC: 6377148. DOI: 10.1371/journal.pbio.2006767. View

3.
Garrido-Castro A, Lin N, Polyak K . Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019; 9(2):176-198. PMC: 6387871. DOI: 10.1158/2159-8290.CD-18-1177. View

4.
Gomez-Roman N, Grandori C, Eisenman R, White R . Direct activation of RNA polymerase III transcription by c-Myc. Nature. 2003; 421(6920):290-4. DOI: 10.1038/nature01327. View

5.
Grandori C, Cowley S, James L, Eisenman R . The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol. 2000; 16:653-99. DOI: 10.1146/annurev.cellbio.16.1.653. View